Markets:

Overview

News

Currencies

International

Treasuries

Assembly Biosciences, Inc. - Common Stock (NQ:ASMB)

36.23 +0.97 (+2.74%)

Streaming Delayed Price Updated: 11:26 AM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Assembly Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82% ↗

October 24, 2022

Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022 ↗

October 24, 2022

Upgrades

Via Benzinga

Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®

October 24, 2022

From Assembly Biosciences, Inc.

Via GlobeNewswire

Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection ↗

July 21, 2022

Via Benzinga

Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor

October 05, 2022

Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of the board

From Assembly Biosciences, Inc.

Via GlobeNewswire

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Penny Stocks That Could Triple in 2022 ↗

June 22, 2022

Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns.

Via InvestorPlace

Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection ↗

June 06, 2022

Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic Hepatitis B Virus Infection

Via Benzinga

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine ↗

May 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company ↗

April 30, 2022

I-Mab and one of its investors, VMS, have filed for a Hong Kong IPO of a SPAC that will raise funds to acquire a life science company. Also, RVAC Medicines completed a Series B funding that brings...

Via Talk Markets

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 25, 2021

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 24, 2021

Gainers iSpecimen (NASDAQ:ISPC) shares in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 90 Points; Kirkland's Shares Spike Higher ↗

September 02, 2021

Toward the end of trading Thursday, the Dow traded up 0.25% to 35,402.54 while the NASDAQ rose 0.05% to 15,316.38. The S&P also rose, gaining 0.13% to 4,530.11. The U.S. has...

Via Benzinga

Topics Stocks

Dow Up Triple Digits, Poised to Snap Three-Day Skid ↗

September 02, 2021

The Dow Jones Industrial Index is staging a bounce off yesterday's lukewarm trading, last seen up 150 points, and set to snap a three-day losing streak.

Via Talk Markets

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021 ↗

September 13, 2021

Upgrades For Bank of America Corp (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 02, 2021

Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.8...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge ↗

September 02, 2021

Midway through trading Thursday, the Dow traded up 0.42% to 35,461.47 while the NASDAQ rose 0.39% to 15,369.38. The S&P also rose, gaining 0.38% to 4,541.06. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook ↗

September 02, 2021

Following the market opening Thursday, the Dow traded up 0.18% to 35,377.03 while the NASDAQ rose 0.23% to 15,345.05. The S&P also rose, gaining 0.27% to 4,536.45. The U.S....

Via Benzinga

Topics Stocks

65 Biggest Movers From Yesterday ↗

September 03, 2021

Gainers AgileThought, Inc. (NASDAQ: AGIL) shares surged 69.4% to settle at $23.53 on Thursday. AgileThought 13D Filings from Chairman, CEO Manuel Senderos Fernández and...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021 ↗

September 02, 2021

Upgrades For Okta Inc (NASDAQ:

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

September 02, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 02, 2021

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million....

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

September 02, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Assembly Bio Stock Tumbles On Discontinuation Of Hepatitis B Trial ↗

September 02, 2021

Assembly Biosciences Inc (NASDAQ: ASMB) has decided to discontinue the development of ABI-H2158 (2158) following the observation of elevated alanine transaminase...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ:INMB) shares ...

Via Benzinga

10 Stocks Moving In Wednesday's After-Hours Session ↗

September 01, 2021

Gainers INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.